Imperative Care Announces Four Senior Leadership Appointments

February 2, 2024—Imperative Care, which is focused technology to treat stroke, pulmonary embolism, and other vascular diseases, recently announced the appointment of four senior leadership appointments to advance the growth and mission of the company. The company has four businesses focused on addressing specific gaps in treatment and care to impact the entire patient journey.

Chuck Alpuche will serve as Chief Operating Officer (COO), Peter Griffin as Senior Vice President of Operations, Scott Elliott as Chief Legal Officer (CLO), and Daniel Davis as Chief Strategy Officer (CSO).

Fred Khosravi, Imperative Care’s CEO and Chairman, commented in the company’s press release, “This is an inflection point of operational scale and excellence for Imperative Care, and we are thrilled to have Chuck lead this important mission. Chuck and Peter together have made an indelible impact in elevating the treatment of diabetes, and they will turn their attention to doing the same for stroke and thrombectomy care. Scott brings a wealth of legal and strategic expertise that he has amassed through his very distinguished career advising hypergrowth innovative companies. Daniel will continue his important contributions to the future of patient care with his resolute dedication to meaningful innovation.”

Dr. Khosravi added, “We foresee that the knowledge and expertise of these leaders—both within and outside of the medical device industry—will allow Imperative Care to take the next step forward in our mission to innovate and improve the entire continuum of patient care.”

According to the company, COO Alpuche brings more than 40 years of senior operational expertise. He served as the Executive Vice President and COO of Insulet Corporation and spent 30 years at PepsiCo in leadership roles overseeing domestic and international plant operations.

Griffin is a seasoned operations leader with more than 35 years of manufacturing, strategic supplier management, and product development experience. His expertise is in operations management, product development, and supplier management. He most recently held the position of Group Vice President and Chief Procurement Officer at Insulet Corporation.

As CLO, Scott Elliott joins the company with over 30 years of experience as a strategic and legal advisor to high-growth companies and investors in various industries, including medical device. He has acted as outside general counsel for companies at various stages and has advised boards of directors on governance issues, public and private financings, mergers and acquisitions, and other strategic transactions. Most recently, he served as a corporate partner at O’Melveny and Myers, LLP in the mergers and acquisitions group, and was Co-Head of the firm’s Life Sciences Practice.

Daniel Davis will assume the new role of CSO, overseeing the growth and strategic initiatives of Imperative Care’s businesses. Davis has played a key role in Imperative Care’s success and is well positioned to help further advance the company’s mission to elevate care, from detection through recovery, for patients with stroke and other vascular diseases, stated the company.